122 related articles for article (PubMed ID: 31609612)
1. ATBdiscrimination: An in Silico Tool for Identification of Active Tuberculosis Disease Based on Routine Blood Test and T-SPOT.TB Detection Results.
Wu J; Bai J; Wang W; Xi L; Zhang P; Lan J; Zhang L; Li S
J Chem Inf Model; 2019 Nov; 59(11):4561-4568. PubMed ID: 31609612
[TBL] [Abstract][Full Text] [Related]
2. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
[TBL] [Abstract][Full Text] [Related]
4. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
[TBL] [Abstract][Full Text] [Related]
5. Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection.
Luo Y; Xue Y; Liu W; Song H; Huang Y; Tang G; Wang F; Wang Q; Cai Y; Sun Z
BMC Infect Dis; 2022 Dec; 22(1):965. PubMed ID: 36581808
[TBL] [Abstract][Full Text] [Related]
6. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy.
Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY
Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066
[TBL] [Abstract][Full Text] [Related]
7. Machine learning based on routine laboratory indicators promoting the discrimination between active tuberculosis and latent tuberculosis infection.
Luo Y; Xue Y; Song H; Tang G; Liu W; Bai H; Yuan X; Tong S; Wang F; Cai Y; Sun Z
J Infect; 2022 May; 84(5):648-657. PubMed ID: 34995637
[TBL] [Abstract][Full Text] [Related]
8. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
[No Abstract] [Full Text] [Related]
9. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Yuan X; Lin Q; Tang G; Mao L; Song H; Wang F; Sun Z
Int J Clin Pract; 2021 Apr; 75(4):e13831. PubMed ID: 33175465
[TBL] [Abstract][Full Text] [Related]
10. Predicting the Progress of Tuberculosis by Inflammatory Response-Related Genes Based on Multiple Machine Learning Comprehensive Analysis.
Ma S; Peng P; Duan Z; Fan Y; Li X
J Immunol Res; 2023; 2023():7829286. PubMed ID: 37228444
[TBL] [Abstract][Full Text] [Related]
11. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
13. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
Della Bella C; Spinicci M; Grassi A; Bartalesi F; Benagiano M; Truthmann K; Tapinassi S; Troilo A; D'Elios S; Alnwaisri H; Shuralev E; Singh M; Bartoloni A; D'Elios MM
PLoS One; 2018; 13(6):e0197825. PubMed ID: 29856871
[TBL] [Abstract][Full Text] [Related]
14. Higher T-SPOT.TB threshold may aid in diagnosing active tuberculosis?: A real-world clinical practice in a general hospital.
Yang Q; Zhang C; Ruan Q; Zhang W; Zhang H; Li Y; Shao L; Zhang W
Clin Chim Acta; 2020 Oct; 509():60-66. PubMed ID: 32505775
[TBL] [Abstract][Full Text] [Related]
15. The performance of the TBAg/PHA ratio in the diagnosis of active TB disease in immunocompromised patients.
Bosco MJ; Hou H; Mao L; Wu X; Ramroop KD; Lu Y; Mao L; Zhou Y; Sun Z; Wang F
Int J Infect Dis; 2017 Jun; 59():55-60. PubMed ID: 28392318
[TBL] [Abstract][Full Text] [Related]
16. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
17. A Systematic Review on Novel
Meier NR; Jacobsen M; Ottenhoff THM; Ritz N
Front Immunol; 2018; 9():2476. PubMed ID: 30473692
[No Abstract] [Full Text] [Related]
18. Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study.
Zhang L; Cheng X; Bian S; Song Y; Li Q; Gao M; Zhang Y; Shi X; Liu X
PLoS One; 2017; 12(5):e0177850. PubMed ID: 28531231
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the Cepheid 3-gene Host Response Fingerstick Blood Test (MTB-HR) on rapid diagnosis of tuberculosis.
Wu X; Tan G; Ma J; Yang J; Guo Y; Lu H; Ke H; Li M; Tang YW; Sha W; Yu F
Emerg Microbes Infect; 2023 Dec; 12(2):2261561. PubMed ID: 37848021
[No Abstract] [Full Text] [Related]
20. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.
Wayengera M; Kateete DP; Asiimwe B; Joloba ML
BMC Infect Dis; 2018 Mar; 18(1):133. PubMed ID: 29548281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
